HEADER VIRAL PROTEIN 24-DEC-22 8HUR TITLE CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH S217622 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE NSP5; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5, COMPND 5 NSP5,SARS CORONAVIRUS MAIN PROTEINASE; COMPND 6 EC: 3.4.22.69; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS VIRAL PROTEIN-INHIBITOR COMPLEX, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR X.L.ZHOU,J.ZHANG,J.LI REVDAT 2 07-FEB-24 8HUR 1 JRNL REVDAT 1 21-JUN-23 8HUR 0 JRNL AUTH C.LIN,H.JIANG,W.LI,P.ZENG,X.ZHOU,J.ZHANG,J.LI JRNL TITL STRUCTURAL BASIS FOR THE INHIBITION OF CORONAVIRAL MAIN JRNL TITL 2 PROTEASES BY ENSITRELVIR. JRNL REF STRUCTURE V. 31 1016 2023 JRNL REFN ISSN 0969-2126 JRNL PMID 37421945 JRNL DOI 10.1016/J.STR.2023.06.010 REMARK 2 REMARK 2 RESOLUTION. 1.64 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.64 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.58 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.361 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 69574 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.964 REMARK 3 FREE R VALUE TEST SET COUNT : 3454 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.5800 - 4.7889 1.00 2882 167 0.1604 0.1811 REMARK 3 2 4.7889 - 3.8028 0.93 2687 138 0.1532 0.1747 REMARK 3 3 3.8028 - 3.3226 0.84 2365 133 0.1762 0.1988 REMARK 3 4 3.3226 - 3.0190 1.00 2862 142 0.2084 0.2299 REMARK 3 5 3.0190 - 2.8027 1.00 2839 150 0.2191 0.2244 REMARK 3 6 2.8027 - 2.6376 0.67 1923 92 0.2252 0.2724 REMARK 3 7 2.6376 - 2.5055 0.99 2807 161 0.2264 0.2612 REMARK 3 8 2.5055 - 2.3965 1.00 2817 140 0.2245 0.2323 REMARK 3 9 2.3965 - 2.3042 1.00 2848 143 0.2193 0.2519 REMARK 3 10 2.3042 - 2.2247 1.00 2829 144 0.2135 0.2832 REMARK 3 11 2.2247 - 2.1552 1.00 2842 173 0.2150 0.2457 REMARK 3 12 2.1552 - 2.0936 1.00 2836 148 0.2102 0.2263 REMARK 3 13 2.0936 - 2.0385 0.77 2162 117 0.2283 0.2897 REMARK 3 14 2.0385 - 1.9888 1.00 2811 161 0.2154 0.2532 REMARK 3 15 1.9888 - 1.9436 0.75 2151 112 0.2073 0.2827 REMARK 3 16 1.9436 - 1.9022 0.39 1084 50 0.2314 0.2833 REMARK 3 17 1.9022 - 1.8641 0.97 2738 118 0.2277 0.2434 REMARK 3 18 1.8641 - 1.8290 1.00 2892 129 0.2258 0.2374 REMARK 3 19 1.8290 - 1.7963 1.00 2805 129 0.2267 0.2545 REMARK 3 20 1.7963 - 1.7659 1.00 2861 149 0.2418 0.2793 REMARK 3 21 1.7659 - 1.7374 1.00 2804 158 0.2560 0.3084 REMARK 3 22 1.7374 - 1.7107 1.00 2873 146 0.2603 0.2675 REMARK 3 23 1.7107 - 1.6855 1.00 2802 148 0.2737 0.2751 REMARK 3 24 1.6855 - 1.6618 1.00 2851 146 0.2825 0.3361 REMARK 3 25 1.6618 - 1.6400 1.00 2749 160 0.3074 0.3245 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.203 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.654 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.21 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4637 REMARK 3 ANGLE : 0.833 6334 REMARK 3 CHIRALITY : 0.053 721 REMARK 3 PLANARITY : 0.006 815 REMARK 3 DIHEDRAL : 9.037 2684 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8HUR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 10-JAN-23. REMARK 100 THE DEPOSITION ID IS D_1300034378. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-AUG-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 69635 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.640 REMARK 200 RESOLUTION RANGE LOW (A) : 33.580 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.02800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.64 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.77900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.5, 20% W/V REMARK 280 POLYETHYLENE GLYCOL 10,000, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 49.48250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 3 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP A 56 CG OD1 OD2 REMARK 470 ILE A 59 CG1 CG2 CD1 REMARK 470 ARG A 60 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 ASP A 153 CG OD1 OD2 REMARK 470 TYR A 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 155 CG OD1 OD2 REMARK 470 ARG A 188 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 222 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 270 CG CD OE1 OE2 REMARK 470 MET A 276 CG SD CE REMARK 470 ARG A 279 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 286 CG CD1 CD2 REMARK 470 PHE A 294 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 47 CG CD OE1 OE2 REMARK 470 LEU B 50 CG CD1 CD2 REMARK 470 GLN B 69 CG CD OE1 NE2 REMARK 470 ASN B 72 CG OD1 ND2 REMARK 470 GLN B 74 CG CD OE1 NE2 REMARK 470 ARG B 76 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 100 CG CD CE NZ REMARK 470 LYS B 102 CG CD CE NZ REMARK 470 ASN B 119 CG OD1 ND2 REMARK 470 LYS B 137 CG CD CE NZ REMARK 470 ASP B 153 CG OD1 OD2 REMARK 470 TYR B 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP B 155 CG OD1 OD2 REMARK 470 ARG B 222 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 223 CG CD1 CD2 CE1 CE2 CZ REMARK 470 THR B 224 OG1 CG2 REMARK 470 ASP B 245 CG OD1 OD2 REMARK 470 GLN B 256 CG CD OE1 NE2 REMARK 470 GLU B 270 CG CD OE1 OE2 REMARK 470 ASN B 277 CG OD1 ND2 REMARK 470 ARG B 279 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 286 CG CD1 CD2 REMARK 470 PHE B 294 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 298 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CE MET B 165 C29 7YY B 401 1.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -129.34 51.78 REMARK 500 ASN A 84 -122.20 52.51 REMARK 500 PRO A 184 44.29 -88.35 REMARK 500 ASP B 33 -127.91 51.90 REMARK 500 ASN B 51 75.89 -158.23 REMARK 500 ASN B 84 -127.66 56.49 REMARK 500 PRO B 184 36.87 -84.44 REMARK 500 REMARK 500 REMARK: NULL DBREF 8HUR A 3 300 UNP P0DTC1 R1A_SARS2 3266 3563 DBREF 8HUR B 3 300 UNP P0DTC1 R1A_SARS2 3266 3563 SEQRES 1 A 298 PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU GLY SEQRES 2 A 298 CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU ASN SEQRES 3 A 298 GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO ARG HIS SEQRES 4 A 298 VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO ASN TYR SEQRES 5 A 298 GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN PHE LEU SEQRES 6 A 298 VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY HIS SEQRES 7 A 298 SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL ASP THR SEQRES 8 A 298 ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG ILE SEQRES 9 A 298 GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR ASN SEQRES 10 A 298 GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG PRO SEQRES 11 A 298 ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SER CYS SEQRES 12 A 298 GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SER SEQRES 13 A 298 PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY VAL SEQRES 14 A 298 HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR GLY PRO SEQRES 15 A 298 PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR ASP SEQRES 16 A 298 THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU TYR ALA SEQRES 17 A 298 ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ARG PHE SEQRES 18 A 298 THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET LYS SEQRES 19 A 298 TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP ILE SEQRES 20 A 298 LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL LEU SEQRES 21 A 298 ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN ASN GLY SEQRES 22 A 298 MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU LEU GLU SEQRES 23 A 298 ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS SEQRES 1 B 298 PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU GLY SEQRES 2 B 298 CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU ASN SEQRES 3 B 298 GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO ARG HIS SEQRES 4 B 298 VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO ASN TYR SEQRES 5 B 298 GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN PHE LEU SEQRES 6 B 298 VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY HIS SEQRES 7 B 298 SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL ASP THR SEQRES 8 B 298 ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG ILE SEQRES 9 B 298 GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR ASN SEQRES 10 B 298 GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG PRO SEQRES 11 B 298 ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SER CYS SEQRES 12 B 298 GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SER SEQRES 13 B 298 PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY VAL SEQRES 14 B 298 HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR GLY PRO SEQRES 15 B 298 PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR ASP SEQRES 16 B 298 THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU TYR ALA SEQRES 17 B 298 ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ARG PHE SEQRES 18 B 298 THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET LYS SEQRES 19 B 298 TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP ILE SEQRES 20 B 298 LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL LEU SEQRES 21 B 298 ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN ASN GLY SEQRES 22 B 298 MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU LEU GLU SEQRES 23 B 298 ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS HET 7YY A 401 37 HET 7YY B 401 37 HETNAM 7YY 6-[(6-CHLORANYL-2-METHYL-INDAZOL-5-YL)AMINO]-3-[(1- HETNAM 2 7YY METHYL-1,2,4-TRIAZOL-3-YL)METHYL]-1-[[2,4,5- HETNAM 3 7YY TRIS(FLUORANYL)PHENYL]METHYL]-1,3,5-TRIAZINE-2,4-DIONE FORMUL 3 7YY 2(C22 H17 CL F3 N9 O2) FORMUL 5 HOH *140(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 ASN A 53 ARG A 60 1 8 HELIX 4 AA4 SER A 62 PHE A 66 5 5 HELIX 5 AA5 ILE A 200 ASN A 214 1 15 HELIX 6 AA6 THR A 226 TYR A 237 1 12 HELIX 7 AA7 THR A 243 LEU A 250 1 8 HELIX 8 AA8 LEU A 250 GLY A 258 1 9 HELIX 9 AA9 ALA A 260 GLY A 275 1 16 HELIX 10 AB1 THR A 292 CYS A 300 1 9 HELIX 11 AB2 SER B 10 GLY B 15 1 6 HELIX 12 AB3 HIS B 41 CYS B 44 5 4 HELIX 13 AB4 THR B 45 ASN B 51 1 7 HELIX 14 AB5 ASN B 53 ARG B 60 1 8 HELIX 15 AB6 SER B 62 HIS B 64 5 3 HELIX 16 AB7 ILE B 200 ASN B 214 1 15 HELIX 17 AB8 THR B 226 TYR B 237 1 12 HELIX 18 AB9 THR B 243 LEU B 250 1 8 HELIX 19 AC1 LEU B 250 GLY B 258 1 9 HELIX 20 AC2 ALA B 260 GLY B 275 1 16 HELIX 21 AC3 THR B 292 CYS B 300 1 9 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 LEU A 67 ALA A 70 -1 N ALA A 70 O VAL A 73 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O THR A 25 N CYS A 22 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N SER A 81 O LYS A 88 SHEET 1 AA2 5 LYS A 100 PHE A 103 0 SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O CYS A 128 N PHE A 112 SHEET 1 AA3 3 LYS A 100 PHE A 103 0 SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 AA4 7 VAL B 73 LEU B 75 0 SHEET 2 AA4 7 PHE B 66 ALA B 70 -1 N ALA B 70 O VAL B 73 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N GLN B 19 O GLN B 69 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O THR B 25 N CYS B 22 SHEET 5 AA4 7 VAL B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 AA4 7 VAL B 86 VAL B 91 -1 O LEU B 89 N VAL B 36 SHEET 7 AA4 7 VAL B 77 GLN B 83 -1 N GLN B 83 O VAL B 86 SHEET 1 AA5 5 LYS B 100 PHE B 103 0 SHEET 2 AA5 5 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA5 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA5 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA5 5 SER B 121 ALA B 129 -1 O SER B 123 N ALA B 116 SHEET 1 AA6 3 LYS B 100 PHE B 103 0 SHEET 2 AA6 3 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA6 3 HIS B 172 THR B 175 -1 O THR B 175 N MET B 162 CRYST1 55.720 98.965 59.359 90.00 108.48 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017947 0.000000 0.005999 0.00000 SCALE2 0.000000 0.010105 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017763 0.00000